| 6.94 -0.1 (-1.42%) | 10-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.36  |
1-year : | 10.16 |
| Resists | First : | 8.02 |
Second : | 8.69 |
| Pivot price | 7.58 |
|||
| Supports | First : | 6.92 |
Second : | 5.75 |
| MAs | MA(5) : | 7.08 |
MA(20) : | 7.81 |
| MA(100) : | 8.48 |
MA(250) : | 8.66 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 4.1 |
D(3) : | 6.4 |
| RSI | RSI(14): 24.3 |
|||
| 52-week | High : | 10.67 | Low : | 6.92 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ JYNT ] has closed above bottom band by 18.6%. Bollinger Bands are 92% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.01 - 7.06 | 7.06 - 7.1 |
| Low: | 6.8 - 6.86 | 6.86 - 6.91 |
| Close: | 6.86 - 6.96 | 6.96 - 7.02 |
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.
Tue, 06 Oct 2026
Over 150 more clinics could be developed under rights The Joint reclaimed. - Stock Titan
Thu, 01 Oct 2026
What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate? - Simply Wall Street
Thu, 01 Oct 2026
The Joint Reacquires Texas Development Rights for $8 Million Cash Plus Up to $2 Million Earnout - TradingView
Fri, 07 Aug 2026
The Joint Corp. Reports Second Quarter 2026 Financial Results - The Manila Times
Thu, 06 Aug 2026
The Joint Corp (JYNT) (Q2 2026) Earnings Call Highlights: Refranchising Nears Completion, ... - Yahoo Finance
Thu, 06 Aug 2026
The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 14 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 16.2 (%) |
| Held by Institutions | 69.2 (%) |
| Shares Short | 406 (K) |
| Shares Short P.Month | 400 (K) |
| EPS | 0.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.15 |
| Profit Margin | 6.4 % |
| Operating Margin | 3.2 % |
| Return on Assets (ttm) | 2.3 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 14.3 % |
| Gross Profit (p.s.) | 3.38 |
| Sales Per Share | 4.14 |
| EBITDA (p.s.) | 0.28 |
| Qtrly Earnings Growth | 652.5 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | 49.57 |
| PEG Ratio | 8.8 |
| Price to Book value | 5.98 |
| Price to Sales | 1.67 |
| Price to Cash Flow | 18.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|